Leucapheresis in severe rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
• Severe RA cases often become refractory to conventional treatments, necessitating alternative therapeutic strategies.

Observation:

• Two patients with severe seropositive RA, previously unresponsive to conventional therapies, underwent daily leucapheresis.
• Leucapheresis is a procedure involving continuous cell separation to selectively remove lymphocytes.

Findings:

• Both patients exhibited significant clinical improvement, assessed using standard rheumatological measures of inflammation.
• The reduction in inflammatory markers suggests a positive response to lymphocyte depletion via leucapheresis.

Implications:

• Leucapheresis demonstrates potential as an adjunctive therapy for managing severe, treatment-resistant rheumatoid arthritis.
• Further research is warranted to establish the efficacy and long-term outcomes of leucapheresis in RA management.